46
Participants
Start Date
January 8, 2025
Primary Completion Date
July 31, 2025
Study Completion Date
November 30, 2025
No intervention will be performed as part of this study. However, regardless of the study, all participants will receive neoadjuvant chemotherapy.
All participants will receive neoadjuvant chemotherapy appropriate to the characteristics of their breast cancer as part of their standard care.
RECRUITING
Pamukkale University, Denizli
ATİYE KAŞ ÖZDEMİR
OTHER